Essilor Stellest Lenses Named TIME Best Invention of 2026

Essilor announced that its Stellest lenses were named one of TIME Magazine’s Best Inventions of 2026 in the Health & Wellness category. This recognition highlights the product's role in childhood myopia management, following U.S. FDA De Novo market authorization granted in September 2025. The FDA designation made them the first and only spectacle lenses authorized in the U.S. to slow myopia progression in children, a status supported by clinical trial data comparing them to single-vision lenses. Arnaud Ribadeau Dumas, head of Product & Marketing Optical Categories at EssilorLuxottica, stated the award acknowledges Essilor’s innovation capabilities. Regulatory status and availability may vary by country.